Sugi Predict

Sugi Predict / Compounds / SCHEMBL24252926

SCHEMBL24252926

SCHEMBL24252926

COc1ccc(CNc2nnc(C)c3cc(-c4cc(B(O)O)cc(-c5cccnc5)c4)ccc23)c(OC)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 17/20 0.58
▸ CYP3A4 P08684 17/20 0.58
▸ CYP2D6 P10635 15/20 0.58
▸ CYP2C19 P33261 15/20 0.58
▸ CLK4 Q9HAZ1 13/20 0.58
▸ HSD17B10 Q99714 11/20 0.58
▸ USP2 O75604 10/20 0.58
▸ LMNA P02545 9/20 0.58
▸ MAPK1 P28482 5/20 0.58
▸ CYP2C9 P11712 10/20 0.54
▸ TSHR P16473 9/20 0.51
▸ ALOX15 P16050 6/20 0.47
▸ HIF1A Q16665 5/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ ALDH1A1 P00352 8/20 0.45
▸ MAPT P10636 2/20 0.43
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ KDM4C Q9H3R0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30452030 1.00 CYP1A2 (0.58) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL29015594 0.96 CYP1A2 (0.55) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL30452401 0.89 CYP1A2 (0.61) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL24252794 0.89 CYP1A2 (0.61) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL30452084 0.88 CYP1A2 (0.48) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL24252326 0.88 CYP1A2 (0.48) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL24252777 0.88 CYP1A2 (0.53) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL30451931 0.88 CYP1A2 (0.53) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL24252337 0.84 CYP1A2 (0.43) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL30452057 0.84 CYP1A2 (0.43) CYP1A2CYP3A4CYP2D6CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109920-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON, INC. 2024-04-04 — — US disclosed
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 — — US disclosed
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 — — US disclosed
EP-4185592-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF Annexon, Inc. (US) 2023-05-31 — — EP disclosed
US-20220048930-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON, INC. 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109920-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF CFB, CFH, C9 CYP1A2 2977/4885CYP3A4 2694/4885CYP2D6 2146/4885
US-20220048930-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF CFB, CFH, C9 CYP1A2 2977/4885CYP3A4 2694/4885CYP2D6 2146/4885
US-11814404-B2 Inhibitors of complement factors and uses thereof CFB, CFH, C9 CYP1A2 2977/4885CYP3A4 2694/4885CYP2D6 2146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.